PRESS RELEASE published on 09/09/2025 at 11:30, 10 months 22 days ago Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47% Berenberg initiates coverage on Eckert & Ziegler SE with a "Buy" recommendation and €24 price target, highlighting market position and rising demand for radioisotopes in nuclear medicine Buy Recommendation Eckert & Ziegler SE Nuclear Medicine Berenberg Radioisotopes
BRIEF published on 08/08/2025 at 07:50, 11 months 24 days ago Eckert & Ziegler Reports Earnings Growth in First Half of 2025 Financial Results Profit Growth Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE published on 08/08/2025 at 07:45, 11 months 24 days ago Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025 Eckert & Ziegler SE reports a further increase in earnings in the first half of 2025, with sales of €148.8 million and net income of €21.4 million. Confirmed forecast for 2025: sales around €320 million and EBIT around €78 million Sales Increase Earnings Eckert & Ziegler SE Medical Segment 2025 Forecast
BRIEF published on 08/05/2025 at 11:55, 11 months 27 days ago Eckert & Ziegler Announces Share Split Effective August 2025 Liquidity Frankfurt Stock Exchange Share Split Nuclear Medicine Bonus Shares
PRESS RELEASE published on 08/05/2025 at 11:50, 11 months 27 days ago Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025 Eckert & Ziegler SE implements share split, issuing bonus shares effective August 15, 2025, tripling tradable shares for improved liquidity without changing shareholder percentages Liquidity Share Split Dividend Rights Eckert & Ziegler SE Bonus Shares
BRIEF published on 07/29/2025 at 14:05, 1 year ago Eckert & Ziegler Chosen for Manufacturing Archeus’ ART-101 Radiopharmaceutical Clinical Trial Manufacturing Agreement Radiopharmaceuticals Prostate Cancer ART-101
PRESS RELEASE published on 07/29/2025 at 14:00, 1 year ago Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA Eckert & Ziegler Prostate Cancer Radiopharmaceutical ART-101 Archeus
BRIEF published on 07/28/2025 at 14:35, 1 year ago Eckert & Ziegler Completes Capital Increase, Prepares Share Split Liquidity Eckert & Ziegler Capital Increase Share Split Nuclear Medicine
PRESS RELEASE published on 07/28/2025 at 14:30, 1 year ago Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation. Eckert & Ziegler SE increases capital and prepares for share split, aiming to enhance share liquidity and trading. Leading in isotope-related components for nuclear medicine and radiation therapy Liquidity Eckert & Ziegler Capital Increase Share Split Isotope-related Components
BRIEF published on 07/15/2025 at 14:05, 1 year ago Eckert & Ziegler's Training Program Recognized for Excellence Training Excellence Berlin Chamber Award Trainee Retention Career Prospects Future Applications
Published on 08/01/2026 at 01:20, 22 hours 41 minutes ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 22 hours 46 minutes ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 23 hours 31 minutes ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/01/2026 at 16:35, 7 hours 25 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 4 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 4 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:53, 1 day 5 hours ago Deutsche EuroShop SE: Conversion into a European Company Successfully Completed
Published on 07/31/2026 at 21:00, 1 day 3 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 4 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026